Article
A nationwide survey of MYH9-related disease in Japan.
Clinical and experimental nephrology - 1 Jan 2024
Shirai Yoko, Miura Kenichiro, Hamada Riku, Ishikura Kenji, Kunishima Shinji, Hattori Motoshi
Abstract excerpt
BACKGROUND: MYH9-related disease (MYH9-RD) is characterized by congenital macrothrombocytopenia, Döhle body-like granulocyte inclusions, and nephropathy, which may progress to end-stage kidney disease (ESKD). However, information on the effects of renin-angiotensin system (RAS) inhibitors on kidney survival is currently lacking and the outcomes of kidney replacement therapy (KRT) in MYH9-RD are largely unknown....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
